Eduardo Collantes

Summary

Country: Spain

Publications

  1. pmc A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
    Eduardo Collantes
    Hospital Reina Sofia, Cordoba, Spain
    BMC Fam Pract 3:10. 2002
  2. ncbi request reprint Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain
    Eduardo Collantes-Estevez
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Spain
    Curr Med Res Opin 19:402-10. 2003
  3. ncbi request reprint Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
    E Collantes-Estevez
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Cordoba
    Rheumatology (Oxford) 44:1555-8. 2005
  4. pmc Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis
    Ruxandra Schiotis
    Rheumatology Department, Hospital Universitario Reina Sofia, Avda Menendez Pidal s n, 14004 Cordoba, Spain
    Rheumatology (Oxford) 50:132-6. 2011
  5. ncbi request reprint Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)
    Raquel Almodovar
    Department of Rheumatology, Hospital Universitario Fundacion Alcorcon, Madrid, Spain
    Clin Exp Rheumatol 29:822-7. 2011
  6. ncbi request reprint [Assessing the efficacy of non-arthroscopic joint lavage in patients with osteoarthritis of the knee]
    Gabriel Frías
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Espana
    Reumatol Clin 5:189-93. 2009
  7. ncbi request reprint Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis
    Veronica C Pérez-Guijo
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Menendez Pidal, S N, 14004 Cordoba, Spain
    Joint Bone Spine 74:254-8. 2007
  8. doi request reprint Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases
    Montserrat Feijoo
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain
    Pharmacology 83:211-6. 2009
  9. doi request reprint Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
    Nuria Montala
    Department of Rheumatology, Hospital Santa Maria, Lleida, c Alcalde Rovira Roure 44, Lleida, Spain
    J Rheumatol 38:893-7. 2011
  10. pmc First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)
    Marena Rojas-Vargas
    Rheumatology Department, Hospital Universitario Reina Sofia, HU Reina Sofía, Cordoba, Spain
    Rheumatology (Oxford) 48:404-9. 2009

Collaborators

  • Loreto Carmona
  • Nuria Montala
  • J Gratacos
  • Manuel Fernandez
  • C Gonzalez
  • Eduardo Collantes-Estevez
  • Pilar Font
  • Raquel Almodovar
  • Elisa Muñoz-Gomariz
  • Juan Mulero
  • Xavier Juanola
  • Ruxandra Schiotis
  • Alejandro Escudero
  • Estefania Moreno
  • Carlos Montilla
  • Pedro Zarco
  • Marena Rojas-Vargas
  • Gabriel Frías
  • Montserrat Feijoo
  • Veronica C Pérez-Guijo
  • E Collantes-Estevez
  • Pedro Zarco-Montejo
  • Rafael Ariza Ariza
  • Rafael Ariza
  • María Cruz Fernández-Espartero
  • Virginia Villaverde
  • Adela Ruiz
  • Inmaculada Tasset
  • Veronica Perez-Guijo
  • Pilar Fernández Dapica
  • Eduardo Cuende Quintana
  • Juan Carlos Torre Alonso
  • María C Castro
  • Enrique Batlle Gualda
  • Teresa Clavaguera Poch
  • Miguel A Caracuel
  • Manuel Fernandez Prada
  • Maria Elia Brito
  • Antonio Juan Mas
  • Isaac Tunez
  • Pedro Montilla
  • Ana Rita Cravo
  • Maria del Carmen Castro
  • R Sanmarti
  • P Zarco
  • J C Torre-Alonso
  • M C Muñoz-Villanueva
  • J D Canete
  • Cristina Fernandez-Perez

Detail Information

Publications10

  1. pmc A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]
    Eduardo Collantes
    Hospital Reina Sofia, Cordoba, Spain
    BMC Fam Pract 3:10. 2002
    ..Etoricoxib is a highly selective COX-2 inhibitor which was evaluated for the treatment of rheumatoid arthritis (RA)...
  2. ncbi request reprint Improved control of osteoarthritis pain and self-reported health status in non-responders to celecoxib switched to rofecoxib: results of PAVIA, an open-label post-marketing survey in Spain
    Eduardo Collantes-Estevez
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Spain
    Curr Med Res Opin 19:402-10. 2003
    ..Determinants of response: Patient characteristics identified in multivariate analysis as predictive of a favourable response to rofecoxib comprised age, obesity, depression, diabetes and OA-related overall health status...
  3. ncbi request reprint Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study
    E Collantes-Estevez
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Cordoba
    Rheumatology (Oxford) 44:1555-8. 2005
    ..To evaluate the therapeutic effectiveness of reducing the infliximab dose interval to 6 weeks in spondyloarthropathy patients not responding to 5 mg/kg every 8 weeks...
  4. pmc Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis
    Ruxandra Schiotis
    Rheumatology Department, Hospital Universitario Reina Sofia, Avda Menendez Pidal s n, 14004 Cordoba, Spain
    Rheumatology (Oxford) 50:132-6. 2011
    ..To present the usefulness of a centralized system of data collection for the development of an international multicentre registry of SpA...
  5. ncbi request reprint Phenotypic differences between familial versus sporadic ankylosing spondylitis: a cross-sectional Spanish registry of spondyloarthropathies (REGISPONSER)
    Raquel Almodovar
    Department of Rheumatology, Hospital Universitario Fundacion Alcorcon, Madrid, Spain
    Clin Exp Rheumatol 29:822-7. 2011
    ..To analyse potential differences in disease phenotype between patients with familial ankylosing spondylitis (AS) and sporadic AS...
  6. ncbi request reprint [Assessing the efficacy of non-arthroscopic joint lavage in patients with osteoarthritis of the knee]
    Gabriel Frías
    Servicio de Reumatologia, Hospital Universitario Reina Sofia, Cordoba, Espana
    Reumatol Clin 5:189-93. 2009
    ..To evaluate the efficacy of joint lavage in patients with osteoarthritis of the knee...
  7. ncbi request reprint Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis
    Veronica C Pérez-Guijo
    Department of Rheumatology, Reina Sofia University Hospital of Córdoba, Menendez Pidal, S N, 14004 Cordoba, Spain
    Joint Bone Spine 74:254-8. 2007
    ..The aims of this study were to assess the efficacy of infliximab (IFX) combined with methotrexate (MTX) versus IFX alone in the treatment of ankylosing spondylitis (AS)...
  8. doi request reprint Infliximab reduces myeloperoxidase concentration in chronic inflammatory joint diseases
    Montserrat Feijoo
    Departamento de Bioquimica y Biologia Molecular, Facultad de Medicina, Universidad de Cordoba, Cordoba, Spain
    Pharmacology 83:211-6. 2009
    ..In conclusion: (1) the MPO concentration is related to inflammatory activity and could play an important role in the maintenance and outbreak of oxidative stress present in these diseases, and (2) infliximab inhibits MPO concentration...
  9. doi request reprint Prevalence of vertebral fractures by semiautomated morphometry in patients with ankylosing spondylitis
    Nuria Montala
    Department of Rheumatology, Hospital Santa Maria, Lleida, c Alcalde Rovira Roure 44, Lleida, Spain
    J Rheumatol 38:893-7. 2011
    ..Our objective was to estimate the prevalence of vertebral fractures in a representative Spanish population of patients with AS using a validated semiquantitative method, MorphoXpress(®)...
  10. pmc First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early)
    Marena Rojas-Vargas
    Rheumatology Department, Hospital Universitario Reina Sofia, HU Reina Sofía, Cordoba, Spain
    Rheumatology (Oxford) 48:404-9. 2009
    ..To determine the first signs and symptoms, and the clinical, biological and radiological characteristics of patients with early SpA...